UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 4 | April 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 9 Issue 2
February-2022
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2202136


Registration ID:
319948

Page Number

b327-b345

Share This Article


Jetir RMS

Title

NOVEL METHOD DEVELOPMENT, VALIDATION, AND STABILITY INDICATING ASSAY METHOD FOR EVOGLIPTIN TARTRATE IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC

Abstract

To develop a novel, simple, precise, accurate, reproducible, and validate stability indicating assay method by RP-HPLC for determination of Evogliptin tartrate in the pharmaceutical dosage form. The adequate separation was achieved on Hypersil BDS C18 (250 mm x 4.6 mm 5 µ) column in isocratic mode with a mobile phase consisting of methanol: water: TFA mixture (70: 30: 0.1% v/v) with flow rate 1 ml/min. The detection was carried out at 264 nm. The retention time of Evogliptin tartrate API and tablet was found to be 4.03 min and 4.02 min respectively. The method was validated as per ICH guidelines. Linearity was established for Evogliptin tartrate in the range of 75.25-225.75 µg/ml with an R2 value of 0.999. The mean recovery of Evogliptin tartrate was found to be in the range of 100.58 ± 0.4. The stress degradation studies of Evogliptin tartrate were carried out under acidic, basic, peroxide, thermal and photolytic conditions. Degradation was observed in acid and base stressed sample, but not in peroxide, thermal, and photolytic stressed sample. The proposed method was found to be specific, accurate, precise, and robust can be used for estimation of Evogliptin tartrate in API and pharmaceutical dosage form.

Key Words

NOVEL METHOD DEVELOPMENT, VALIDATION, AND STABILITY INDICATING ASSAY METHOD FOR EVOGLIPTIN TARTRATE IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC

Cite This Article

"NOVEL METHOD DEVELOPMENT, VALIDATION, AND STABILITY INDICATING ASSAY METHOD FOR EVOGLIPTIN TARTRATE IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 2, page no.b327-b345, February-2022, Available :http://www.jetir.org/papers/JETIR2202136.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"NOVEL METHOD DEVELOPMENT, VALIDATION, AND STABILITY INDICATING ASSAY METHOD FOR EVOGLIPTIN TARTRATE IN PHARMACEUTICAL DOSAGE FORM BY RP-HPLC", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 2, page no. ppb327-b345, February-2022, Available at : http://www.jetir.org/papers/JETIR2202136.pdf

Publication Details

Published Paper ID: JETIR2202136
Registration ID: 319948
Published In: Volume 9 | Issue 2 | Year February-2022
DOI (Digital Object Identifier):
Page No: b327-b345
Country: -, -, India .
Area: Engineering
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000423

Print This Page

Current Call For Paper

Jetir RMS